2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Enrolling by invitation
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Other
4
CNS
4
Thoracic
3
Gastrointestinal
3
Classical hematology
3
Head & Neck
2
Gynecologic
2
Genitourinary
2
Dermatologic
2
Plasma cell
1
Other solid neoplasm
1
Lymphoid
1
Endocrine
1
Breast
1
Conditions
Prostatic Neoplasms
6276
Carcinoma, Renal Cell
1915
Urinary Bladder Neoplasms
1672
Kidney Neoplasms
931
Breast Neoplasms
794
Neoplasms
791
Carcinoma, Transitional Cell
597
Carcinoma, Non-Small-Cell Lung
525
Neoplasm Metastasis
511
Melanoma
486
Ovarian Neoplasms
470
Colorectal Neoplasms
456
Lung Neoplasms
436
Pancreatic Neoplasms
326
Testicular Neoplasms
290
Stomach Neoplasms
274
Sarcoma
267
Uterine Cervical Neoplasms
265
Non-Muscle Invasive Bladder Neoplasms
264
Head and Neck Neoplasms
242
Colonic Neoplasms
217
Esophageal Neoplasms
203
Squamous Cell Carcinoma of Head and Neck
202
Carcinoma, Hepatocellular
200
Wilms Tumor
196
Endometrial Neoplasms
191
Recurrence
162
Urologic Neoplasms
149
Neuroblastoma
148
Small Cell Lung Carcinoma
146
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Amyotrophic Lateral Sclerosis
×
Genitourinary
×
Clear all
NCT06583395
2024-11-01
QUANTUM
VitaMed Research LLC
Enrolling by invitation
3,000 enrolled
NCT03516994
2024-05-16
EQUALACP
Duke University
Phase NA
Completed
790 enrolled